HomeNYMXF • OTCMKTS
Follow
Nymox Pharmaceutical Corp
Previous close
$0.41
Day range
$0.32 - $0.36
Year range
$0.12 - $1.27
Market cap
32.26M USD
Avg Volume
17.26K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.01M | -31.53% |
Net income | -1.04M | 30.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.01M | 28.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 76.00K | -97.19% |
Total assets | 669.00K | -78.70% |
Total liabilities | 2.57M | 8.57% |
Total equity | -1.90M | — |
Shares outstanding | 93.26M | — |
Price to book | -20.49 | — |
Return on assets | -539.36% | — |
Return on capital | 127.93% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.04M | 30.52% |
Cash from operations | -1.26M | 3.29% |
Cash from investing | 0.00 | — |
Cash from financing | 1.21M | 2,111.67% |
Net change in cash | -56.00K | 95.90% |
Free cash flow | -873.45K | -16.85% |
About
Founded
1989
Website
Employees
3